These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11011241)

  • 21. Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France.
    Clinard F; Sgro C; Bardou M; Dumas M; Hillon P; Bonithon-Kopp C
    Pharmacoepidemiol Drug Saf; 2001; 10(4):329-38. PubMed ID: 11760495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy with oral antidiabetic drugs].
    Kautzky-Willer A; Lechleitner M; Pieber TR; Prager R; Roden M; Wascher TC; Weitgasser R
    Acta Med Austriaca; 2004; 31(5):162-3. PubMed ID: 15747987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.
    Liberman JN; Berger JE; Lewis M
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):357-64. PubMed ID: 19349565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The increase in the use of drug treatment for diabetes mellitus in the Netherlands, 1998-2003].
    Langendam MW; Hooijkaas C; Piepenbrink JF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1396-401. PubMed ID: 16841589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001.
    Wysowski DK; Armstrong G; Governale L
    Diabetes Care; 2003 Jun; 26(6):1852-5. PubMed ID: 12766122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Practice of antidiabetic therapy in Hungary].
    Hankó BZ; Reszegi CA; Kumli P; Vincze Z
    Acta Pharm Hung; 2005; 75(2):77-86. PubMed ID: 16318232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
    Nau DP; Chao J; Aikens JE
    Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oral antidiabetic drugs in 2003].
    Ducobu J
    Rev Med Brux; 2003 Sep; 24(4):A361-8. PubMed ID: 14606302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among Military Health System beneficiaries, fiscal year 2003-2006.
    Casscells SW; Granger E; Swedorske J; Goldhammer R; Shaheen M; Dorris J; Hong A; Wiktor M
    Am J Ther; 2008; 15(3):198-205. PubMed ID: 18496256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of the medical treatment of diabetes in Luxembourg].
    Perquin M; Keipes M; Wirion R; Haas N; de Beaufort CE; Michel GH
    Bull Soc Sci Med Grand Duche Luxemb; 2006; (1):29-35. PubMed ID: 16869094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.
    Patel H; Srishanmuganathan J; Car J; Majeed A
    J Public Health (Oxf); 2007 Mar; 29(1):48-52. PubMed ID: 17124257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study.
    Brauchli YB; Jick SS; Curtin F; Meier CR
    J Am Acad Dermatol; 2008 Mar; 58(3):421-9. PubMed ID: 18194825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Underuse of cardioprotective treatment by the elderly with type 2 diabetes.
    Sirois C; Moisan J; Poirier P; Grégoire JP
    Diabetes Metab; 2008 Apr; 34(2):169-76. PubMed ID: 18396087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis.
    Kalsekar ID; Madhavan SS; Amonkar MM; Douglas SM; Makela E; Elswick BL; Scott V
    Clin Ther; 2006 Feb; 28(2):306-18. PubMed ID: 16678652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
    Willey CJ; Andrade SE; Cohen J; Fuller JC; Gurwitz JH
    Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feature selection and classification model construction on type 2 diabetic patients' data.
    Huang Y; McCullagh P; Black N; Harper R
    Artif Intell Med; 2007 Nov; 41(3):251-62. PubMed ID: 17707617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When oral agents fail: optimizing insulin therapy in the older adult.
    Meece J
    Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.